Study | Patients included | Mean age [years] | Mean follow-up [years] | % statin use | % PPI use | % diabetes | % male |
---|---|---|---|---|---|---|---|
British Doctors’ Study | 5139 | 61 | 6 | Unknown | Unknown | 2 | 100 |
US Physicians’ Health Study | 22,071 | 53 | 5 | Unknown | Unknown | 2 | 100 |
Thrombosis Prevention Trial | 5085 | 57 | 6.8 | Unknown | Unknown | 2 | 100 |
Hypertension Optimal Treatment Trial | 18,790 | 61 | 3.8 | Unknown | Unknown | 8 | 53 |
Primary Prevention Project | 4495 | 64 | 3.6 | Unknown | Unknown | 17 | 43 |
Women’s Health Study | 39,876 | 54 | 10.1 | Unknown | Unknown | 3 | 0 |
POPADAD trial | 1276 | 60 | 6.7 | Unknown | Unknown | 100 | 44 |
JPAD trial | 2539 | 65 | 10.3 | 26 | 8.6** | 100 | 55 |
AAA trial | 3350 | 62 | 8.2 | Unknown | Unknown | 3 | 28 |
JPPP trial | 14,464 | 71 | 5 | Unknown | Unknown | 34 | 42 |
ARRIVE trial | 12,546 | 64 | 5 | Unknown | Unknown | 0 | 70 |
ASCEND trial | 15,480 | 63 | 7.4 | 75 | Approx. 25 | 94.1 | 63 |
ASPREE trial | 19,114 | 74* | 4.7 | 34 | 24.7 | 11 | 44 |
all studies included | 164,225 | 62 | 6.4 (IQR 4.85–7.8) |  |  |  |  |